Shareholders

CURADIGM ANNOUNCES 1 MILLION € FUNDING FROM BPI FRANCE’S DEEP TECH PROGRAM TO SUPPORT DEVELOPMENT OF THE NANOPRIMER PLATFORM

CURADIGM ANNOUNCES 1 MILLION € FUNDING FROM BPI FRANCE’S DEEP TECH PROGRAM TO SUPPORT DEVELOPMENT OF THE NANOPRIMER PLATFORM

Curadigm today announced the receipt of 1 Million € in non-dilutive funding from Deep Tech BPI France for the development of their Nanoprimer technology. The Deep Tech program recognizes biotechnology companies with breakthrough innovation and strong commercial potential. The funding award highlights the Nanoprimer’s unique, groundbreaking approach to increasing therapeutic bioavailability and efficacy, which is applicable across multiple drug classes. […]

Continue Reading...